We are actively enrolling patients into this exciting study evaluating a new medication to treat type 2 diabetes and obesity. You may be eligible to enroll in the trial if you meet the following criteria:
Eligible patients who enroll in the trial will receive free medication, free assessments of your diabetes and heart disease risk factors and reimbursement for your time.